BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21951063)

  • 1. Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide.
    Merighi S; Gessi S; Varani K; Simioni C; Fazzi D; Mirandola P; Borea PA
    Br J Pharmacol; 2012 Mar; 165(6):1773-1788. PubMed ID: 21951063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells.
    Merighi S; Gessi S; Varani K; Fazzi D; Mirandola P; Borea PA
    Br J Pharmacol; 2012 Aug; 166(8):2371-85. PubMed ID: 22428664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling.
    Correa F; Mestre L; Docagne F; Guaza C
    Br J Pharmacol; 2005 Jun; 145(4):441-8. PubMed ID: 15821753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling.
    Ma L; Jia J; Liu X; Bai F; Wang Q; Xiong L
    Biochem Biophys Res Commun; 2015 Feb; 458(1):92-7. PubMed ID: 25637536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine mediates a proinflammatory phenotype via μ-opioid receptor-PKCɛ-Akt-ERK1/2 signaling pathway in activated microglial cells.
    Merighi S; Gessi S; Varani K; Fazzi D; Stefanelli A; Borea PA
    Biochem Pharmacol; 2013 Aug; 86(4):487-96. PubMed ID: 23796752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2.
    Olea-Herrero N; Vara D; Malagarie-Cazenave S; Díaz-Laviada I
    Br J Cancer; 2009 Sep; 101(6):940-50. PubMed ID: 19690545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats.
    Mathison R; Ho W; Pittman QJ; Davison JS; Sharkey KA
    Br J Pharmacol; 2004 Aug; 142(8):1247-54. PubMed ID: 15249429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells.
    Zhong LM; Zong Y; Sun L; Guo JZ; Zhang W; He Y; Song R; Wang WM; Xiao CJ; Lu D
    PLoS One; 2012; 7(2):e32195. PubMed ID: 22363816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effects of genistein via suppression of the toll-like receptor 4-mediated signaling pathway in lipopolysaccharide-stimulated BV2 microglia.
    Jeong JW; Lee HH; Han MH; Kim GY; Kim WJ; Choi YH
    Chem Biol Interact; 2014 Apr; 212():30-9. PubMed ID: 24491678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro.
    Tang J; Tao Y; Tan L; Yang L; Niu Y; Chen Q; Yang Y; Feng H; Chen Z; Zhu G
    Neuropharmacology; 2015 Aug; 95():424-33. PubMed ID: 25963415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
    Gómez-Gálvez Y; Palomo-Garo C; Fernández-Ruiz J; García C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():200-8. PubMed ID: 25863279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific PKC isoforms regulate LPS-stimulated iNOS induction in murine microglial cells.
    Wen J; Ribeiro R; Zhang Y
    J Neuroinflammation; 2011 Apr; 8():38. PubMed ID: 21510893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine suppresses lipopolysaccharide-stimulated BV2 microglial cells by suppressing Akt-mediated NF-κB activation and ERK phosphorylation.
    Kang CH; Jayasooriya RG; Dilshara MG; Choi YH; Jeong YK; Kim ND; Kim GY
    Food Chem Toxicol; 2012 Dec; 50(12):4270-6. PubMed ID: 22974838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cells.
    Wang YP; Wu Y; Li LY; Zheng J; Liu RG; Zhou JP; Yuan SY; Shang Y; Yao SL
    J Neuroinflammation; 2011 Aug; 8():95. PubMed ID: 21831303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol is anti-inflammatory in BV2 microglial cells by inactivating nuclear factor-kappaB and inhibiting mitogen-activated protein kinases.
    Jung WK; Lee DY; Park C; Choi YH; Choi I; Park SG; Seo SK; Lee SW; Yea SS; Ahn SC; Lee CM; Park WS; Ko JH; Choi IW
    Br J Pharmacol; 2010 Mar; 159(6):1274-85. PubMed ID: 20128801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory properties of tianeptine on lipopolysaccharide-induced changes in microglial cells involve toll-like receptor-related pathways.
    Slusarczyk J; Trojan E; Glombik K; Piotrowska A; Budziszewska B; Kubera M; Popiolek-Barczyk K; Lason W; Mika J; Basta-Kaim A
    J Neurochem; 2016 Mar; 136(5):958-70. PubMed ID: 26640965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB.
    Correa F; Hernangómez M; Mestre L; Loría F; Spagnolo A; Docagne F; Di Marzo V; Guaza C
    Glia; 2010 Jan; 58(2):135-47. PubMed ID: 19565660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycoepoxydiene inhibits activation of BV2 microglia stimulated by lipopolysaccharide through suppressing NF-κB, ERK 1/2 and toll-like receptor pathways.
    Su X; Chen Q; Chen W; Chen T; Li W; Li Y; Dou X; Zhang Y; Shen Y; Wu H; Yu C
    Int Immunopharmacol; 2014 Mar; 19(1):88-93. PubMed ID: 24447679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel synthetic HTB derivative, BECT inhibits lipopolysaccharide-mediated inflammatory response by suppressing the p38 MAPK/JNK and NF-κB activation pathways.
    Kang SM; More SV; Park JY; Kim BW; In PJ; Yoon SH; Choi DK
    Pharmacol Rep; 2014 Jun; 66(3):471-9. PubMed ID: 24905526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.